E
Editas Medicine
EDIT · NASDAQ · Healthcare
$2.88
$0.02 (-0.69%) today
Loading live data...
Market Cap
$442.31M
24h Volume
$4.9M
P/E Ratio
-2.4
52w High
$4.15
52w Low
$1.66
Est. AI Revenue
10%
Loading chart data...
7-Day Sparkline (Static)
About Editas Medicine
Gene editing company using AI and ML to optimize CRISPR-based therapeutic development and guide RNA design.
CEO: Gilmore O'Neill
Founded: 2013
HQ: Cambridge, Massachusetts
Employees: 87
Performance
24 Hours-0.69%
7 Days+11.63%
30 Days-12.73%
1 Year+30.32%